Literature DB >> 10818008

Reperfusion in acute myocardial infarction. Ensuring early reperfusion, by whatever means, is the best strategy for now.

N M Robinson, A D Timmis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10818008      PMCID： PMC1118033          DOI： 10.1136/bmj.320.7246.1354

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.

Authors:  F Zijlstra; J C Hoorntje; M J de Boer; S Reiffers; K Miedema; J P Ottervanger; A W van 't Hof; H Suryapranata
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

2.  Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators.

Authors:  E M Antman; R P Giugliano; C M Gibson; C H McCabe; P Coussement; N S Kleiman; A Vahanian; A A Adgey; I Menown; H J Rupprecht; R Van der Wieken; J Ducas; J Scherer; K Anderson; F Van de Werf; E Braunwald
Journal:  Circulation       Date:  1999-06-01       Impact factor: 29.690

3.  Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial.

Authors:  C M Nunn; W W O'Neill; D Rothbaum; G W Stone; J O'Keefe; P Overlie; B Donohue; L Grines; K F Browne; R E Vlietstra; T Catlin; C L Grines
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

4.  Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the "real world": one-year results from a nationwide French survey.

Authors:  N Danchin; L Vaur; N Genès; S Etienne; M Angioï; J Ferrières; J P Cambou
Journal:  Circulation       Date:  1999-05-25       Impact factor: 29.690

5.  Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. Investigators in the National Registry of Myocardial Infarction.

Authors:  W J Rogers; J G Canto; H V Barron; J A Boscarino; D A Shoultz; N R Every
Journal:  J Am Coll Cardiol       Date:  2000-02       Impact factor: 24.094

6.  Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group.

Authors:  C L Grines; D A Cox; G W Stone; E Garcia; L A Mattos; A Giambartolomei; B R Brodie; O Madonna; M Eijgelshoven; A J Lansky; W W O'Neill; M C Morice
Journal:  N Engl J Med       Date:  1999-12-23       Impact factor: 91.245

7.  Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

Authors: 
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

8.  Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.

Authors:  C P Cannon; C H McCabe; D J Diver; S Herson; R M Greene; P K Shah; R F Sequeira; F Leya; J M Kirshenbaum; R D Magorien
Journal:  J Am Coll Cardiol       Date:  1994-12       Impact factor: 24.094

9.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-11-25       Impact factor: 91.245

10.  Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.